The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


AstraZeneca refines endpoints in immuno-oncology trials for NSCLC.....           Evgen Pharma doses first patient in phase II breast cancer trial.....           Clinigen begins US Managed Access program for TESARO?s niraparib in ovarian cancer patients.....           Biogen to pay Forward Pharma $1.25bn to settle multiple sclerosis drug case.....           European Commission approves Suliqua to treat adults with type 2 diabetes.....           Supreme Court takes up Amgen, Sandoz's market-defining biosimilars dispute.....           Drugmakers 'hijacked' the FDA's orphan system to score premium pricing on mass-market meds: report.....           Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers.....           Allergan's Esmya inches closer to U.S. approval, but FDA label is key to its blockbuster fate.....           With Flublok at a standstill in Japan, Astellas ditches cell-culture vax collab.....           Scottish Medicines Consortium approves Zepatier to treat chronic hepatitis C.....           Malin buys 33% interest in UK's Wren Therapeutics.....           Chi-Med starts phase II study of sulfatinib in second-line biliary tract cancer in China.....           Horizon Discovery broadens gene editing capabilities.....           MonoSol Rx files patent infringement case against BioDelivery Sciences International.....           What'd you miss at J.P. Morgan? Everything you need to know, all in one place.....           Sunovion?s dasotraline improves ADHD symptoms in children in phase 2/3 study.....           FDA extends review period by three months for rheumatoid arthritis candidate baricitinib.....           Nivalis Therapeutics unveils corporate restructuring.....           ObsEva completes phase 1 first-in-women study of OBE022 to treat preterm labor.....           Aptevo Therapeutics receives $20m payment from Emergent BioSolutions.....           FiercePharmaAsia: Takeda?s $5.2B deal for Ariad and $125M with Maverick, Valeant?s $820M Dendreon sell to Chinese company, and more.....           Novartis scouts new tech partnerships to build lead on 'risk averse' pharma peers.....           Shire to fork over $350M to settle 'flagrant' Dermagraft kickback claims.....           New York takes drug pricing into its own hands with new clampdown.....           US appeals court upholds Eli Lilly's patent on Alimta cancer drug.....           Novartis to commence phase 2 trial with bimagrumab in obese patients with type 2 diabetes.....           FDA grants QIDP status for RedHill's RHB-104 to treat nontuberculous mycobacteria infections.....           Clinical-stage biopharmaceutical firm OncoImmune raises $15m funding.....           Heron submits CINVANTI NDA to FDA for CINV prevention.....           Bioverativ remind you of Baxalta? Get ready for a different M&A outcome, execs say.....           Amid insulin market scrutiny, Novo faces class action alleging 'collusive price fixing'.....           Tesaro gets CRL tied to CMC questions for chemo-related nausea drug.....           AbbVie chief joins the 10% price-hike pledge, but other CEOs aren't buying it.....           Deal-talkers J&J, Actelion reportedly land on a price, but spinoff details still pending.....           Allergan CEO: 2017 should be Kybella's breakout year.....           Eli Lilly's Alimta escapes early generics?and a sales hit?with patent win over Teva.....           FDA to review Biocon and Mylan's biosimilar drug for breast cancer.....           FDA grants orphan drug status for Sangamo?s SB-318 genome editing treatment for MPS I.....           Gilead gets European approval for hepatitis B drug Vemlidy.....           Visterra doses first patient in phase 2a trial of influenza A candidate VIS410.....           Merck expands oncology portfolio with four Vertex cancer programs.....           JPM need-to-know, Chapter 2: Pfizer's deal hunger; Sanofi's dupilumab rollout and more.....           Biopharma aghast as Trump taps vaccines skeptic Kennedy to lead safety commission: reports.....           BMS' Eliquis is 'relatively close' to snagging market lead from J&J's Xarelto, CEO says.....           Surprise Keytruda-chemo FDA filing puts Merck ahead in I-O combo race.....           Trump to pharma: You're 'getting away with murder,' and I'm the one to stop it.....           Valeant Pharmaceuticals agrees to divest $2.1bn in assets.....           FDA accepts Merck's sBLA for lung cancer combo therapy.....           Gilead awards more than $22m in grants to support HIV cure research.....           Debiopharm unveils positive phase 2 trial with Debio 1450 in ABSSSI patients.....           ValiRX?s prostate cancer drug VAL201 shows positive results in Phase l/II trial.....           Genzyme CEO's dupilumab goal? Getting it to the right patients, just like a rare-disease drug.....           Rapid growth spurs McCann Health to recruit ex-Publicis HR exec as its first global chief talent officer.....           Top 20 pharma brands dropped more than $2B on national TV ads last year.....           Top 20 pharma brands dropped more than $2 billion on national TV ads last year.....           JPM: Wondering how Teva overestimated 2017 sales by $1B-plus? Let CEO Vigodman explain.....           Regeneron CEO: Amgen's disruptive Praluent-blocking patent move hurts patients.....           Don?t get too excited about U.S. corporate tax reform, pharma. It may not all be pretty.....           Celgene on track for $21B-plus by 2020, execs say, as they unveil 2017 guidance.....           Humira finishes year as strong as it started, grabbing No. 1 TV spender spot for December.....           Bavarian Nordic sees 'huge potential' in cancer vaccine combos, CEO says.....           Pfizer wants deals that can pad sales 'now or soon.' And it's not waiting for tax reform.....           Takeda to buy Ariad Pharmaceuticals for $5.2bn.....           Silence Therapeutics acquires minority stake in Arrowhead Pharmaceuticals.....           Cumberland Pharmaceuticals, Clinigen sign US commercialization deal for Totect.....           Ipsen to buy Merrimack's global oncology assets.....           Zebra Biologics to partner with AbbVie on new antibody therapeutics discovery.....           FDA approves Egalet?s opioid prescription painkiller.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
PharmSci 2017 - first announcement

Tuesday 5 - Thursday 7 September 2017 at De Havilland Campus, University of Hertfordshire, Hatfield

The theme of the conference in 2017 is:
'Pharmaceutical Science without Borders'

The APS is pleased to announce Professor Abdul Basit as this year's Conference Science Chair.

Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.

"I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is "Pharmaceutical Science without Borders". Pharmaceutical science transcends a multitude of borders - it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event."

You can become part of this conference now.

Reserve the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.

Please also regularly check the PharmSci website for updates.
 

PharmSci 2016 Conference - Chair's review

The Chair of the Academy of Phamaceutical Sciences, Dr Linda Hakes, gives a brief review of the 7th APS International PharmSci Conference, held in Glasgow on 5-7 September 2016.

"2016 has come to an end and although I admit that I am probably biased, I think it was a fantastic three days. The venue, the Technology and Innovation Centre at Strathclyde University, was well equipped to handle the conference and the facilities are modern and efficient.

All of the conference sessions (as far as I could tell) were well attended and the plenary lectures were all excellent, covering topics ranging across the spectrum of pharmaceutical sciences, embracing chemistry, pharmacology, medical devices, formulation, pharmacokinetics and spectroscopy.

A highlight of the social side was the Civic Reception in the City Chambers, a magnificent building on George Square, where we were warmly welcomed by the Bailey Steward on behalf of the Lord Provost of Glasgow.

 

 

 

 

 

As always the Black Tie Dinner was a great success and we were pleased to have Prof. Sandy Florence as guest speaker. Again, the venue was truly impressive – the Barony Hall.

 

 

 

 


To sum up, I believe we enjoyed a conference full of good science, excellent networking opportunities, and highly enjoyable social events. If you weren’t there, why not make a note for next year –
Tuesday 5 - Thursday 7 September 2017 at the University of
Hertfordshire .

See you there!"

Latest News
APS 8th International PharmSci Conference 2017 Call fro Abstracts
THURSDAY, 12 JANUARY 2017
. 'Pharmaceutical Sciences Without Borders’. Tuesday 5 – Thursday 7 September 2017 De Havilland Campus of the University of Hertfordshire in Hatfield. Call for Abstracts. Abstracts are invited for posters for APS International PharmSci 2017. This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.. Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, 'Pharmaceutical Sciences Without Borders’ are particularly appreciated. Details of the various subject categories, an abstract template and details of the entry process can be found here:. http://www.ukpharmsci.org/abstracts/default.asp. Please ensure abstracts are submitted online and comply with the Abstract Submission Template. Please note one or two page abstracts are welcomed providing they follow the template.. There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (15min). This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference. The closing date for abstract submission is Friday 17th March 2017.. Abstracts will be made available to Conference registrants when the abstract author has registered for the Conference. We also intend to publish the abstracts in a journal after the Conference and authors not wishing to take up this opportunity are requested to indicate this where indicated when they submit their abstract.. Entrants in the Analytical Chemistry category may be eligible for the Geoffrey Phillips Analytical Science Award, subject to meeting the criteria, awarded by the Joint Pharmaceutical Analysis Group (JPAG). The purpose of the Award is to encourage the advancement of pharmaceutical analysis and to recognise contributions of emerging scientists reporting wholly or mainly their own work. The winner receives a prestigious award with a bursary of up to £1000 to attend a conference relevant to their area of interest.. http://www.jpag.org/?&sid=20170112135948802597&p=awards#award. Exhibitor Opportunities. The conference includes a large pharmaceutical sciences exhibition, which is open to large pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers. With one of the largest gatherings of pharmaceutical scientists in the UK, the conference offers a great opportunity to showcase your company.. For more information please contact us: info@apsgb.org or 0116 274 7351. .
APS Fellowships Announcement 2017
WEDNESDAY, 2 NOVEMBER 2016
Do you know someone who has made a significant contribution to Pharmaceutical Science?. The APS is calling for nominations of candidates to become Fellow or Eminent Fellow of the Academy of Pharmaceutical Sciences.. Nominees for Fellowship must be a member of APS (for at least one year) and have a proven track record in pharmaceutical science, as demonstrated by at least 15 peer-reviewed publications, patents or equivalent. This would include significant contributions to the development of products or medical devises within the pharmaceutical industry. Nominees must also have demonstrated leadership and peer recognition through invited lectures, conference leadership, mentoring of young scientists etc. Candidates may self-nominate and nominations must consist of a one-page summary of achievements accompanies by a CV.. Nominations for Eminent Fellowship may be submitted by any member of APS but self-nominations are not accepted. Nominees for Eminent Fellowship must have international recognition for their advocacy of science and have demonstrated leadership at international level. Nominations should consist of a one-page summary of achievements and an explanation of why Eminent Fellowship is justified, and be accompanied by a CV.. Nominations should be sent to info@apsgb.org by 1 March 2017.
APS 8th International PharmSci Conference 2017
TUESDAY, 1 NOVEMBER 2016
. Tuesday 5 - Thursday 7 September 2017 De Havilland Campus, University of Hertfordshire, Hatfield. The theme of the conference in 2017 is. 'Pharmaceutical Science without Borders'. The APS is pleased to announce Professor Abdul Basit as the Conference Science Chair Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.. “I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is “Pharmaceutical Science without Borders”. Pharmaceutical science transcends a multitude of borders – it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event.”. . You can become part of this conference now,. Reserving the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.. . . . . . .
APS thanks retiring Board members and welcomes Yvonne Perrie and Michael Leane as newly appointed Board members
TUESDAY, 4 OCTOBER 2016
At the AGM on 5 September, held during the PharmSci conference at the Technology and Innovation Centre at Strathclyde University, we formally thanked our two retiring Board members, Richard Storey and Claire Thompson, for all their hard work and support of APS over several years of service. Claire has been an enthusiastic Board member who has been a strong advocate for pharmaceutical science and has been very engaged in outreach to universities, students and young scientists. Richard Storey has served not only as a Board member but has also been our Treasurer for many years, a task which has had many challenges which he has managed in a calm and professional manner. We are very grateful to both of them and hope that they will remain active members and supporters of APS.. . At the AGM we also ratified the selection of Yvonne Perrie (Strathclyde University) and Michael Leane (BMS) as the incoming Board members. We warmly welcome them to the Board and look forward to working with them.
Follow us
 
Upcoming Events
APS Developability Workshop
22 - 23 March 2017
APS Industrial Insights 2017
20 - 21 April 2017
APS Board and Advisory Board Meeting
12 July 2017
APS 8th International PharmSci Conference 2017
5 - 7 September 2017
Job Vacancies
View all Vacancies
Advertise your job vacancies
Sponsored By
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351
Fax: 0116 274 7365
Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.